Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
28
Number of overlapping holdings
47.5%
% of RSPH's 59 holdings also in BMED
26.7%
% of BMED's 115 holdings also in RSPH
Overlap by Weight
Sector Drift (RSPH minus BMED)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in RSPH |
Weight in BMED |
Overlap | |
|---|---|---|---|---|
 |
BOSTON SCIENTIFIC CORP | 1.7% | 4.9% | 1.7% |
|
ABBOTT LABORATORIES | 1.7% | 2.7% | 1.7% |
|
BRISTOL-MYERS SQUIBB CO | 1.7% | 2.2% | 1.7% |
|
EDWARDS LIFESCIENCES CORP | 1.7% | 1.6% | 1.6% |
|
INTUITIVE SURGICAL INC | 1.6% | 4.9% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
RSPH Overweight Relative to BMED
|
UNIVERSAL HEALTH SERVICES-B | 1.8% |
|
HCA HOLDINGS INC | 1.8% |
|
CENCORA INC | 1.8% |
|
ZIMMER HOLDINGS INC | 1.8% |
|
CARDINAL HEALTH INC | 1.8% |
|
UNITEDHEALTH GROUP INC | 1.8% |
|
HUMANA INC | 1.8% |
|
COOPER COS INC/THE | 1.7% |
|
DAVITA INC | 1.7% |
|
ELEVANCE HEALTH INC | 1.7% |
RSPH Underweight Relative to BMED
 |
ROCHE HOLDING AG-BR | -3.4% |
 |
ARGENX SE ADR | -3.3% |
|
INTUITIVE SURGICAL INC | -3.2% |
|
BOSTON SCIENTIFIC CORP | -3.2% |
|
LONZA GROUP AG-REG | -2.7% |
|
UCB SA | -2.2% |
|
REPLIGEN CORP | -2.1% |
|
GILEAD SCIENCES INC | -2.1% |
|
NEUROCRINE BIOSCIENCES INC | -1.5% |
|
NATERA INC | -1.5% |